LexisNexis® Legal Newsroom
Pa. High Court: Drug Company Lacks Standing To Challenge State’s Outside Counsel

PHILADELPHIA - (Mealey's) Janssen Pharmaceutica Inc. lacks standing under Pennsylvania law to challenge the hiring of outside counsel to represent the state in a Risperdal off-label marketing lawsuit, the Pennsylvania Supreme Court ruled Aug. 17 ( Commonwealth of Pennsylvania, et al. v. Janssen Pharmaceutica...

Pennsylvania Panel Reinstates Compensatory, Punitive Damages In Prempro Case

PHILADELPHIA - A Pennsylvania Superior Court panel on Feb. 7 reinstated a $1.68 million compensatory damage verdict and a sealed punitive damage verdict in a state court Prempro case ( Mary Daniel, et al. v. Wyeth Pharmaceuticals, Inc., et al. , Nos. 2626 EDA 2007 and 2690 EDA 2007, Pa. Super.; 2011...

$4 Million Awarded In 1st Pa. Trial Alleging Birth Defect From Topamax Epilepsy Drug

PHILADELPHIA — (Mealey’s) A Pennsylvania jury on Oct. 30 found that Janssen Pharmaceuticals Inc. failed to warn about the risk of birth defects from its Topamax epilepsy drug and awarded the injured minor $4 million in damages (April Czimmer, et al. v. Ortho-McNeil-Janssen Pharmaceutica,...

Pennsylvania State Court Jury Awards $10 Million In 2nd Topamax Birth Defect Trial

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Nov. 18 awarded more than $10 million to a family whose son was born with a cleft palate allegedly caused by his mother’s use of the antiepileptic drug Topamax during pregnancy, according to one of the law firms representing...

Pa. High Court Reconsiders, Won’t Disturb $8.6M Prempro Punitive Damages Award

PHILADELPHIA — (Mealey’s) The Pennsylvania Supreme Court on Dec. 16 let stand an $8.6 million punitive damages verdict in a Prempro hormone replacement therapy case after dismissing the appeal as improvidently granted ( Mary Daniel, et al. v. Wyeth Pharmaceuticals, Inc., et al. , Nos. 63...

Pa. Supreme Court Says Drug Companies Can Be Sued For Marketing Dangerous Drugs

PHILADELPHIA — (Mealey’s) Pennsylvania law allows drug companies to be sued if they fail to stop marketing drugs known to be unreasonably harmful, and the manufacturers are not immune from being sued for damages for lack of due care, the Pennsylvania Supreme Court ruled Jan. 22 in an eight...

Janssen Settles Some Pa. Topamax Birth Defect Cases, Will Appeal $3M Verdict

PHILADELPHIA — (Mealey’s) Topamax manufacturer Janssen Pharmaceuticals on March 10 said it will appeal a $3 million March 7 birth defect verdict in the Philadelphia County Common Pleas Court even though it reached an agreement to resolve a number of similar cases in the state court, including...

Pa. Supreme Court Vacates $27.7M Drug Pricing Judgment Against Bristol-Myers

HARRISBURG, Pa. — (Mealey’s) The Pennsylvania Supreme Court on June 16 vacated a $27.7 million drug pricing judgment against drug maker Bristol-Myers Squibb Co. (BMS) because a trial court failed to account for billions of dollars in drug rebates paid to the state government ( Commonwealth...

Pennsylvania Appeals Court Affirms $10M Children’s Motrin TEN Injury Verdict

PHILADELPHIA — (Mealey’s) A Pennsylvania appeals court panel on July 22 affirmed a $10 million Children’s Motrin verdict for a girl who suffered toxic epidermal necrolysis (TEN) after being given the over-the-counter pain/fever reducer at age 3 ( Alicia E. Maya, et al. v. Johnson and...

Pennsylvania State Court Jury Awards Plaintiff $2 Million In Actos Bladder Cancer Case

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Oct. 3 awarded an Actos bladder cancer patient $2.05 million in economic and noneconomic damages but declined to award punitive damages ( Frances Wisniewski v. Takeda Pharmaceuticals America Inc., et al. , No. 120702272, Pa. Comm...

Pennsylvania State Court Jury Awards $2.5 Million In Risperdal Gynecomastia Trial

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Feb. 24 awarded $2.5 million to the family of a man who claimed that the atypical antipsychotic drug Risperdal caused gynecomastia, or enlarged male breasts ( P.P., et al. v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., et al. ,...

McNeil Pleads Guilty, Pays $25M For Making Adulterated Children’s Medicines

PHILADELPHIA — (Mealey’s) The McNeil-PPC Inc. subsidiary of Johnson & Johnson on March 10 pleaded guilty to a federal misdemeanor criminal charge of making adulterated children’s over-the-counter medicines and agreed to pay a criminal fine and forfeiture totaling $25 million ( United...

U.S. High Court Denies Review Of Last Pending Appeal Of Generic Label-Update Claim

WASHINGTON, D.C. — (Mealey’s) The U.S. Supreme Court on May 18 denied review in the last pending “failure-to-update-warnings” preemption appeal by generic drug manufacturers ( Teva Pharmaceuticals USA, Inc., et al. v. Paul E. Hassett , No. 14-705, U.S. Sup. [lexis.com subscribers...